Horizon Therapeutics PLC (HZNP)
88.65
+2.46 +2.85%
NASDAQ
Mar 5, 20:00
USD
View All Key Stats
Key Stats
Income Statement | |
Revenue (TTM) | 2.200B |
Revenue (Quarterly YoY Growth) | Upgrade |
EPS Diluted (TTM) | 1.64 |
EPS Diluted (Quarterly YoY Growth) | Upgrade |
Net Income (TTM) | 389.80M |
Profitability | |
Gross Profit Margin (Quarterly) | 78.23% |
Profit Margin (Quarterly) | 25.57% |
Dividend | |
Dividend Yield (Forward) | Upgrade |
Dividend Yield | 0.00% |
Price and Valuation | |
Market Cap | 19.86B |
52 Week High (Daily) | Upgrade |
52 Week Low (Daily) | Upgrade |
PS Ratio | 8.478 |
PE Ratio | 54.05 |
Price to Book Value | 4.934 |
Other | |
Beta (5Y) | Upgrade |
Debt to Equity Ratio | 0.2493 |
Free Cash Flow (Quarterly) | 343.36M |
Return on Equity | Upgrade |
View All HZNP News
News
-
WireHeadlineTime (ET)
-
Yahoo02/26 16:05
-
Yahoo02/25 16:05
-
Yahoo02/25 15:27
-
Yahoo02/25 12:03
-
Yahoo02/24 16:41
-
Yahoo02/24 16:11
-
MT Newswires02/24 15:58
-
MT Newswires02/24 13:21
-
Yahoo02/24 11:01
-
SA Breaking News02/24 10:19
-
MT Newswires02/24 09:17
-
MT Newswires02/24 07:15
-
SA Breaking News02/24 07:06
-
MT Newswires02/24 07:01
-
MT Newswires02/24 07:01
-
Yahoo02/24 07:00
-
SA Breaking News02/23 11:45
-
SA Breaking News02/23 11:19
-
Yahoo02/22 09:30
-
PR Newswire02/20 20:33
View All Events
Events
Date | Type | Description |
---|---|---|
05/06/2021 | Earnings | Horizon Therapeutics PLC First Quarter Earnings Results for 2021 |
05/06/2021 | Misc | Horizon Therapeutics PLC First Quarter Earnings Conference Call for 2021 |
02/24/2021 | Earnings | Horizon Therapeutics PLC Fourth Quarter Earnings Result for 2020 |
02/24/2021 08:00 EST | Misc | Horizon Therapeutics PLC Fourth Quarter Earnings Conference Call for 2020 |
11/02/2020 | Earnings | Horizon Therapeutics PLC Third Quarter Earnings Result for 2020 |
11/02/2020 08:00 EST | Misc | Horizon Therapeutics PLC Third Quarter Earnings Conference Call for 2020 |
08/05/2020 08:00 EDT | Misc | Horizon Therapeutics PLC Second Quarter Earnings Conference Call for 2020 |
08/05/2020 | Earnings | Horizon Therapeutics PLC Second Quarter Earnings Result for 2020 |
05/06/2020 08:00 EDT | Misc | Horizon Therapeutics PLC First Quarter Earnings Conference Call for 2020 |
05/06/2020 | Earnings | Horizon Therapeutics PLC First Quarter Earnings Result for 2020 |
Fundamentals
Income Statement View Statement
Ratings & Reports
- Y-Rating Upgrade
- Value Score Upgrade
- Fundamental Score Upgrade
- Valuation (Hist. Mult.) Upgrade
- Y-Rating Report Download
- One Page Report Download
Advertisement
Edit
Profile
- URL: https://www.horizontherapeutics.com
- Investor Relations URL: http://ir.horizon-pharma.com/
- HQ State/Province: N/A
- Sector: Healthcare
- Industry: Drug Manufacturers - General
- Equity Style: Mid Cap/Growth
- Next Earnings Release: May. 06, 2021
- Last Earnings Release: Feb. 24, 2021
- Next Ex-Dividend Date: N/A
- Last Ex-Dividend Date: N/A
- Description: Horizon Therapeutics PLC is a specialty and generic drug manufacturing company. The company is focused on researching, developing and commercializing medicines that address critical needs for people impacted by rare and rheumatic diseases. The company has two reportable segments: orphan and rheumatology segment and the inflammation segment. It markets medicines in the areas of orphan diseases, rheumatology and inflammation division. The majority of revenue is generated in the United States.
Analyst Coverage
Consensus Recommendations | |
Buy Recommendations | Upgrade |
Outperform Recommendations | Upgrade |
Hold Recommendations | Upgrade |
Underperform Recommendations | Upgrade |
Sell Recommendations | Upgrade |
Consensus Recommendation | Upgrade |
Consensus Rating | Upgrade |
Target Price | |
Price | 88.65 |
Price Target | Upgrade |
Price Target Upside (Daily) | Upgrade |
Top Fund Holders
Symbol | Name | Weighting |
---|---|---|
XPH | SPDR® S&P Pharmaceuticals ETF | 4.88% |
JCNIX | Janus Henderson Contrarian S | 3.95% |
HQL | Tekla Life Sciences Investors | 2.75% |
WSMRX | William Blair Small-Mid Cap Growth R6 | 2.25% |
HQH | Tekla Healthcare Investors | 1.59% |
DBMCX | BNY Mellon Sm/Md Cp Gr C | 1.55% |
JFNSX | Janus Henderson Global Life Sciences S | 1.31% |
VISGX | Vanguard Small Cap Growth Index Inv | 0.70% |
VBK | Vanguard Small-Cap Growth ETF | 0.70% |
BBMC | JPMorgan BetaBuilders US Mid Cap Eq ETF | 0.60% |
VB | Vanguard Small-Cap ETF | 0.34% |
NAESX | Vanguard Small Cap Index Inv | 0.33% |
Other Resources
- 13F Filings Whale Wisdom
- Call Transcripts Seeking Alpha
- Insider Trading Morningstar
- Institutional Ownership Nasdaq
- SEC Filings SEC
- HZNP Tweets Stocktwits
Advertisement